Home › Upcoming votes › bioAffinity Technologies, Inc.
The deadline as the proxy statement states it: “voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on November 19, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in bioAffinity Technologies, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | August 2026 warrant share issuance (Nasdaq) | Board | For | — |
| 2 | October 2026 warrant share issuance (Nasdaq) | Board | For | — |
| 3 | Authorization to issue securities in non-public offerings (Nasdaq 5635(d)) | Board | For | — |
| 4 | Decrease authorized common shares from 350,000,000 to 200,000,000 | Board | For | — |
| 5 | Adjournment proposal Adjournment |
Board | For | — |
From bioAffinity Technologies, Inc.’s Form 8-K, filed July 25, 2025, for the meeting held July 25, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Maria Zannes | 99% | Elected |
| Elect Director: Steven Girgenti | 99% | Elected |
| Elect Director: Robert Anderson | 99% | Elected |
| Elect Director: Peter Knight | 99% | Elected |
| Elect Director: Gary Rubin | 96% | Elected |
| Elect Director: Roby Joyce, MD | 99% | Elected |
| Elect Director: Jamie Platt, PhD | 99% | Elected |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm | 97% | Approved |
| 3. Reverse Stock Split Proposal | 81% | Approved |
| 4. Issuance of Shares of Common Stock Upon Exercise of Warrants | 88% | Approved |
| 5. Share Increase Amendment to the Certificate of Incorporation | 82% | Approved |
| 6. Anti-Dilution Adjustment Proposal | 87% | Approved |
| 7. Adjournment of the Annual Meeting | 84% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.